Phase
Condition
N/ATreatment
HeRO® Graft System or Super HeRO® System
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria:
Subject provides written informed consent
Subject is ≥ 18 years
Subject is end-stage renal disease patient on hemodialysis.
Subject is treated with HeRO Graft or Super HeRO System in accordance with deviceinstructions for use (IFU)
Exclusion
Key Exclusion Criteria:
Subject has a previously placed HeRO or Super HeRO device that is undergoingrevision or replacement
Subject has a topical or subcutaneous infection associated with the implantationsite
Subject has known or suspected systemic infection, bacteremia or septicemia
Study Design
Connect with a study center
Baylor Scott & White Heart and Vascular Hospital - Dallas
Dallas, Texas 75226
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.